Home > Boards > US Listed > Biotechs > Sage Therapeutics, Inc. (SAGE)

We’ll most likely see a jump back to

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
NYCPuglet Member Profile
 
Followed By 26
Posts 2,384
Boards Moderated 0
Alias Born 08/20/15
160x600 placeholder
Sage Therapeutics to Report Third Quarter 2019 Financial Results on Tuesday, November 12, 2019 Business Wire - 10/9/2019 6:30:00 AM
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire - 10/2/2019 4:30:00 PM
Sage Therapeutics to Participate in J.P. Morgan Executive Conference Call Series Business Wire - 10/2/2019 6:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/12/2019 5:01:02 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/5/2019 4:34:04 PM
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire - 9/5/2019 4:31:00 PM
Sage Therapeutics Announces the New England Journal of Medicine Publishes Data from Phase 2 Trial with SAGE-217 in Major Depr... Business Wire - 9/4/2019 5:05:00 PM
Sage Therapeutics to Present at the Morgan Stanley Global Healthcare Conference Business Wire - 9/3/2019 5:31:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/16/2019 4:04:53 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/6/2019 7:17:52 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/6/2019 7:05:44 AM
Sage Therapeutics Announces Second Quarter 2019 Financial Results and Highlights Pipeline and Business Progress Business Wire - 8/6/2019 6:30:00 AM
Sage Therapeutics to Present at 2019 Wedbush PacGrow Healthcare Conference Business Wire - 8/5/2019 4:30:00 PM
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire - 8/5/2019 6:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/25/2019 6:02:50 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/24/2019 7:19:41 AM
Sage Therapeutics Announces Clinical Updates and Progress Across Neuroscience Pipeline During “Sage FutureCast” Business Wire - 7/24/2019 6:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/17/2019 4:03:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/17/2019 4:02:38 PM
Sage Therapeutics to Report Second Quarter 2019 Financial Results on Tuesday, August 6, 2019 Business Wire - 7/11/2019 6:30:00 AM
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Business Wire - 7/3/2019 6:30:00 AM
Sage Therapeutics to Host “Sage FutureCast” Webcast Business Wire - 6/27/2019 6:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 5:19:16 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 5:19:16 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 5:19:05 PM
NYCPuglet   Wednesday, 12/12/18 12:08:46 AM
Re: None
Post # of 81 
We’ll most likely see a jump back to $150 by 1/15/19.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist